Raman spectroscopy—a method of evaluating substances by shining monochromatic light over a sample and seeing the emerging dispersed light—has frustrated biologists for more than fifty years. During the optical measurements, the heat generated by the light nearly kills living proteins, leading to decreased and non-repeatable findings. It appears that these hassles may be the past as of late. A team of scientists has created a novel method that enables low-dose and low-concentration screens of protein-ligand interactions under physiologically realistic circumstances. This novel method, called thermostable Raman interaction profiling (TRIP), offers label-free, highly reproducible Raman spectroscopy data and is a paradigm-shifting solution to a long-standing issue.
Scientists have discovered that temperature and substrate temperature may significantly impact the interaction between proteins and ligands, essential for immunological responses, gene regulation, and signal transduction.
TRIP may expedite drug and vaccine testing because of its real-time detection of protein-ligand interactions. Another use would be clinical, where long-term viral detection tests might be completed on the same day and yield reliable findings.
The spectroscopic statute concentrates on sample preparation, necessitating little to none, so clinical analysis may happen immediately. Testing using the TRIP approach is more affordable since it provides a lower protein concentration and a smaller sample quantity.
The group is investigating how well the thermostable Raman interaction profiling (TRIP) approach works for determining the chemical makeup of proteins and how it may be extended to analyze DNA and other biological components without sample preparation.
Related Content: Neutron Spin Echo Spectroscopy